NCT01758432View on ClinicalTrials.gov

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 1 of 4)

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy Volunteers
Interventions
COMBINATION_PRODUCT

PRT064445/Apixaban

COMBINATION_PRODUCT

Placebo/Apixaban

DRUG

Placebo

Trial Locations (1)

85283

Tempe

Sponsors
All Listed Sponsors
lead

Portola Pharmaceuticals

INDUSTRY

NCT01758432 - Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 1 of 4) | Biotech Hunter | Biotech Hunter